101 results
Page 2 of 6
8-K
EX-99.1
7e1wx5vwzr lh9
8 Aug 23
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
8:04am
8-K
m7kwied559432ydc3dm
8 Aug 23
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
8:04am
8-K
xlcrksf3kb4a
27 Jul 23
Results of Operations and Financial Condition
7:32am
8-K
EX-99.1
1vg jhy8rtwe3bw
27 Jul 23
Results of Operations and Financial Condition
7:32am
8-K
EX-99.1
y1a1j k0zmb71
15 Jun 23
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
7:38am
S-3ASR
ac1f4
9 May 23
Automatic shelf registration
4:10pm
8-K
EX-99.1
cxgfd 5gi
9 May 23
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
7:11am
8-K
EX-99.1
5da9g4g8
22 Dec 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
q3rn676 efrno
7 Nov 22
Entry into a Material Definitive Agreement
4:05pm
424B5
uk5sj3 40
7 Nov 22
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
aidyt6bqk5 jir
7 Nov 22
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
7:10am
8-K
EX-99.1
ua713cm2riiu
6 Oct 22
Mersana Therapeutics Announces Completion of Enrollment in UPLIFT, a
4:21pm
8-K
EX-99.1
499vb9iq4ucv
16 Aug 22
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-1660 in Breast, Endometrial and Ovarian Cancers
8:18am